Table 2 Baseline characteristics of each cohort
Before | After | ∆ | |
|---|---|---|---|
No. of manuscripts submitted in timeframe | 310 | 301 | − 9 |
No. of manuscripts included in analysis | 300 | 290 | − 10 |
No. with applicable reporting guidelines | 224 (75%) | 217 (75%) | 0.2% |
ARRIVE | 18 (6.0%) | 14 (4.8%) | − 1.2% |
CARE | 38 (13%) | 24 (8.3%) | − 4.4% |
CONSORT | 10 (3.3%) | 20 (6.9%) | 3.6% |
ENTREQ | 2 (0.67%) | 0 (0.0%) | − 0.7% |
MOOSE | 3 (1.0%) | 0 (0.0%) | − 1.0% |
PRISMA | 18 (6.0%) | 21 (7.2%) | 1.2% |
REMARK | 11 (3.7%) | 4 (1.4%) | − 2.3% |
SQUIRE | 0 (0.0%) | 2 (0.07%) | 0.7% |
STARD | 6 (2.0%) | 12 (4.1%) | 2.1% |
SRQR | 12 (4.0%) | 12 (4.1%) | 0.1% |
STROBE | 106 (35%) | 106 (37%) | 1.2% |
TRIPOD | 0 (0.0%) | 2 (0.07%) | 0.7% |